Cardiac effects 2 years after successful non-myeloablative human leukocyte antigen-matched related donor hematopoietic cell transplants in sickle cell disease.
作者信息
Sachdev Vandana, Limerick Emily, Nguyen My-Le, Li Wen, Jeffries Neal, Ramachandra Shalini, Tofovic David, Rondelli Damiano, Al Zahrani Mohsen, Aljizeeri Ahmed, Saraf Santosh, Hsieh Matthew, Fitzhugh Courtney D
机构信息
NHLBI, National Institutes of Health, Bethesda, Maryland, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.
出版信息
Am J Hematol. 2023 Aug;98(8):E219-E221. doi: 10.1002/ajh.26985. Epub 2023 Jun 7.
Abstract
摘要
相似文献
1
Cardiac effects 2 years after successful non-myeloablative human leukocyte antigen-matched related donor hematopoietic cell transplants in sickle cell disease.镰状细胞病患者成功接受非清髓性人类白细胞抗原匹配相关供体造血细胞移植2年后的心脏影响
Am J Hematol. 2023 Aug;98(8):E219-E221. doi: 10.1002/ajh.26985. Epub 2023 Jun 7.
2
Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.非清髓性 HLA 匹配同胞供体异基因造血干细胞移植治疗严重镰状细胞表型。
JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192.
3
HLA-matched related donor hematopoietic stem cell transplantation is a suitable treatment in adolescents and adults with sickle cell disease: Comparison of myeloablative and non-myeloablative approaches.人类白细胞抗原匹配的相关供体造血干细胞移植是镰状细胞病青少年和成人患者的一种合适治疗方法：清髓性和非清髓性方法的比较。
Am J Hematol. 2022 Sep;97(9):E359-E362. doi: 10.1002/ajh.26656. Epub 2022 Jul 23.
4
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.供体类型和预处理方案强度对镰状细胞病患者异基因移植结局的影响：一项回顾性多中心队列研究
Lancet Haematol. 2019 Nov;6(11):e585-e596. doi: 10.1016/S2352-3026(19)30154-1. Epub 2019 Sep 5.
5
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.降低毒性的清髓性人类白细胞抗原半相合造血干细胞移植联合移植后环磷酰胺治疗镰状细胞病
Ann Hematol. 2017 Aug;96(8):1373-1377. doi: 10.1007/s00277-017-3030-x. Epub 2017 Jun 1.
6
Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.镰状细胞病的造血干细胞移植：不断变化的形势。
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):259-266. doi: 10.1016/j.hemonc.2017.05.008. Epub 2017 Jun 15.
7
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.非清髓性人类白细胞抗原匹配相关供体移植治疗镰状细胞病：来自三个独立中心的结果。
Br J Haematol. 2021 Feb;192(4):761-768. doi: 10.1111/bjh.17311. Epub 2021 Feb 3.
8
Lung function after matched-related donor allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.镰状细胞病患儿接受匹配相关供体异基因造血干细胞移植后的肺功能
Am J Hematol. 2023 Aug;98(8):E212-E215. doi: 10.1002/ajh.26967. Epub 2023 May 22.
9
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.采用减强度预处理方案和第三方间充质基质细胞对血红蛋白病患者进行无关供体同种异体造血干细胞移植。
Biol Blood Marrow Transplant. 2014 Apr;20(4):581-6. doi: 10.1016/j.bbmt.2013.12.564. Epub 2013 Dec 24.
10
Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.采用清髓性预处理和中等剂量兔抗胸腺细胞球蛋白的同胞全相合供者造血干细胞移植治疗重型镰状细胞病的疗效
Pediatr Blood Cancer. 2014 Sep;61(9):1685-9. doi: 10.1002/pbc.25059. Epub 2014 Apr 17.
引用本文的文献
1
Reply to Holbert and Fraidenburg: Not to Be Forgotten. Pulmonary Vascular Effects of Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.回复霍尔伯特和弗赖登伯格：不可遗忘。非清髓性造血细胞移植治疗镰状细胞病的肺血管效应。
Ann Am Thorac Soc. 2025 Apr;22(4):628-629. doi: 10.1513/AnnalsATS.202412-1253LE.
2
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis.异基因造血干细胞移植对镰状细胞病相关器官并发症的影响：系统评价和荟萃分析。
Am J Hematol. 2024 Jun;99(6):1129-1141. doi: 10.1002/ajh.27297. Epub 2024 Mar 22.
3
Improvement in Cardiac Morphology Demonstrated by Cardiac Magnetic Resonance Imaging and Echocardiography after Haploidentical Hematopoietic Cell Transplantation in Adults with Sickle Cell Disease.心脏磁共振成像和超声心动图显示成人镰状细胞病患者接受单倍体造血细胞移植后的心脏形态改善。
Transplant Cell Ther. 2024 Feb;30(2):231.e1-231.e9. doi: 10.1016/j.jtct.2023.11.007. Epub 2023 Nov 10.
本文引用的文献
1
Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy.儿童镰状细胞贫血患者心脏异常的纵向分析及羟基脲治疗的效果。
Blood Adv. 2021 Nov 9;5(21):4406-4412. doi: 10.1182/bloodadvances.2021005076.
2
The different risk factors for isolated diastolic hypertension and isolated systolic hypertension: a national survey.孤立性舒张期高血压和孤立性收缩期高血压的不同危险因素：一项全国性调查。
BMC Public Health. 2021 Sep 14;21(1):1672. doi: 10.1186/s12889-021-11686-9.
3
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.非清髓性人类白细胞抗原匹配相关供体移植治疗镰状细胞病：来自三个独立中心的结果。
Br J Haematol. 2021 Feb;192(4):761-768. doi: 10.1111/bjh.17311. Epub 2021 Feb 3.
4
Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease.镰状细胞病行造血干细胞移植后血流动力学心肌病的逆转。
Blood Adv. 2019 Oct 8;3(19):2816-2824. doi: 10.1182/bloodadvances.2019000387.
5
High-Output Heart Failure in Sickle Cell Anemia.
JACC Cardiovasc Imaging. 2016 Sep;9(9):1122-1123. doi: 10.1016/j.jcmg.2016.04.004.
6
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.舒张功能障碍是镰状细胞病患者死亡的独立危险因素。
J Am Coll Cardiol. 2007 Jan 30;49(4):472-9. doi: 10.1016/j.jacc.2006.09.038. Epub 2007 Jan 16.
Zotero 插件